WORLD VACCINES 2027

HIV vaccines

Submit Abstract Register Now

The Human immunodeficiency virus (HIV) vaccine can either protect individuals from being infected with HIV or treat HIV-infected individuals. The virus can be transmitted through infected blood, sexual intercourse (semen or vaginal fluids). AIDS also called Acquired Immunodeficiency Syndrome is caused by HIV where it interferes with the body’s ability to fight infections. Common symptoms of AIDS include weight loss, fever, fatigue, and recurrent infections. An HIV vaccine can either induce an immune response against HIV or consist of preformed antibodies against HIV. Two active HIV vaccine regimens are studied in the RV 144 and Imbokodo trials, which showed the results that it helped to prevent HIV in some individuals. However, the protection was observed in only a few individuals and was not long-lasting results. For these reasons, no HIV vaccines have been licensed in the market yet but research is still going on.                             

Related associations and societies: National Institutes of Health (NIH) , Immune Deficiency Foundation (IDF),National Institute of Allergy and Infectious Diseases (NIAID), National Medical Association (NMA),  Federation of Clinical Immunology Societies (FOCIS), Asia Pacific Association of Allergy, Asthma and Clinical Immunology (APAAACI), Clinical Immunology Society, Hepatitis B Foundation (HBF), Pediatric Infectious Diseases Society(PIDS), Indian Vaccine Manufacturers Association (IVMA).